Abstract
Nanoscience and nanotechnology have advanced in recent years followed by groundbreaking discoveries that allow a remarkable control of molecular entities in the nanoscale. Advances in the field still came in many cases without a detailed and profound understanding on the effects and impact that nanotechnology and nanomaterials can have in our future society. In this work, we have aimed to provide a short but relevant overview on the impact and risks of nanotechnogy and the possibilities to engineer safer nanomaterials for a controllable working environment.
Introduction
Nanotechnology is a relatively new field of science which has already shown a significant number of possibilities in fields including medicine, diagnostics, and biosensing [1–3]. The contribution of nanomaterials in many parts of science has become very significant due to the exceptional properties of these nanoentities (degenerated density of energy states and small sizes), remarkably different as compared to their non-nano counterparts. Nanosizes have associated large surface areas, useful for many applications, which also makes them a particularly delicate health hazard to exposed scientists. Nanotechnology deals with particles (or aggregates) in which one of their dimensions is within the nanometer-range (10–9 m). Since particles tend to have special surface properties at increasingly smaller sizes, nanomaterials are currently considered as versatile and tunable materials for a myriad of applications [1–3]. These include medicinal (as liposome nanovectors that deliver nanosized contrasting agents for imaging purposes [2, 3]), diagnostics [4] and electronics [5]. Needless to say, nanotechnology has become one of the most explored fields in modern research due to its overlapping applications across all other branches of science.
Why should there be a point of concern for nanomaterials?
Useful as they may seem, nanomaterials are a point of concern for many laboratories worldwide. Because of their very small size (as seen in Fig. 1), they can enter the body through a variety of routes and effectively have unknown effects in living organisms. Several laboratories worldwide have recently adopted a more specialized safety policy in handling nanoparticles.

Examples of synthesized gold nanomaterials.
Pulmonary studies in the past suggest that smaller particles are able to pass the normal macrophage defense of the pulmonary system, and that these particles tend to deposit on the lungs and eventually obstruct normal breathing [1, 6]. Other nanomaterials such as carbon nanotubes, graphene, and metal nanoparticles have different sets of hazards and dangers that should be taken seriously for proper precautions.
In this contribution, we aim to provide an overview of techniques that can be used to synthesize nanoparticles and assess their nanotoxicity. Further, management protocols on laboratory safety and handling of nanomaterials will be discussed.
Molecular mechanisms of cell death associated with nanomaterials
Due to the very small size of engineered nanomaterials, the number of ways that they can enter the human body is significant. Because of these possible implications of nanoparticles to human health, it is essential to understand the molecular mechanisms involved in the uptake and fate of these particles. Furthermore, it is necessary to understand which molecular pathways are affected so to eventually create a cure that can be administered in cases of excessive exposure.
Engineered nanoparticles can interact with living cells [7]. The work of Pan et al. [8] recently showed that the cytoxicity of gold nanoparticles is size dependent, with nanoparticle size also dictating the molecular cell death route (Fig. 2). Cell lines of different types were tested with different AuNP sizes, with findings indicating that connecting tissue fibroblasts, epithelial cells, macrophages, and melanoma cells were sensitive to nanoparticles. Smaller AuNP (1.2 nm) could cause cell necrosis while slightly larger particles (1.4 nm) allowed for apoptosis to happen. This work clearly illustrates that small differences in size could practically redirect a particular molecular pathway for cell death. Large nanoparticles were observed to undergo endocytosis and impair lyposomes to trigger either receptor-mediated or mitochondria-mediated pathways (for apoptosis). Comparably, smaller particles most likely affect mitochondria membrane potential or activate a surface receptor to injure and cause death to cells.
![Fig. 2 The routes of entry of nanoparticles in the cell could be phagocytic, pinocytic, or a direct penetration. Most nanoparticles with relatively large sizes and ligand modifications enter the cell via the phagocytosis pathway. (Reprinted with permission from Ref. [11], Copyright © 2013 American Chemical Society.)](/document/doi/10.1515/pac-2014-0302/asset/graphic/pac-2014-0302_fig2.jpg)
The routes of entry of nanoparticles in the cell could be phagocytic, pinocytic, or a direct penetration. Most nanoparticles with relatively large sizes and ligand modifications enter the cell via the phagocytosis pathway. (Reprinted with permission from Ref. [11], Copyright © 2013 American Chemical Society.)
Similarly, AgNPs have also been shown to cause cell death by reducing available ATP, damaging the mitochondria membrane as well as increasing the concentration of reactive oxygen species in cells. The cytotoxicity of AgNPs is also similar to reported dose-dependent cytotoxicity of gold [9]. Remarkably, graphene and graphene oxides have also demonstrated several cytotoxicity albeit in less complex life forms such as bacteria [10]. Such cytotoxicity is believed to be also related to the ability of these nanomaterials to aggregate and precipitate, in order to decrease their large surface energies for stabilisation.
As illustrated by CdSe/CdSe-ZnS cytotoxicity studies, no surface receptor and ion channel impairment was found when fluorescence imaging was performed. This conclusion was further supported by the observation that polymer-coated inert AuNPs possessed a similar activity to that of polymer-coated CdSe/CdSe-ZnS, which rules out the possibility of total Cd2+ poisoning. This work adds to the growing evidence of the role of surface functionalization to NP cytotoxicity [10]. Since cell death cascades are activated by ligands that interact with specific receptors present on the cell membrane, a nanoparticle with a similar activating moiety on its surface can effectively trigger cell death – the strength and nature of this interaction being mainly dependent on particle surface properties. Therefore, design and careful selection of nanoparticle synthesis methods can turn an otherwise toxic material into a safe nanoentity.
How to approach a safer nanomaterials synthesis?
There is a growing body of evidence in scientific literature that an effective way of reducing NP toxicity relates to a careful surface design and/or modification for effectiveness (with respect to the target application) and safety [11, 12].
Surface modifications for safer nanoparticles
Biological systems interact with nanoparticles through the surface; this is also the very reason why many nanoparticles have become good drug carriers as well as carriers of other bioactive compounds. Recently, they have been used to selectively deliver chemotherapeutic drugs to cancer cells. In catalysis, they are functionalized with catalytic functional groups to help address mass transfer issues in heterogeneous systems due to their large surface areas and tendency to aggregate/coalescence to stabilize [13]. In this section, we will discuss the different possible methods by which NPs can be functionalized with safer functional groups.
Graphene
Graphene is a carbon allotrope comprising sp2 hybridized carbon atoms arranged as a monolayer and in a honeycomb lattice. Due to its interesting electronic properties, it has attracted a remarkable deal of attention in recent years. Graphene is usually prepared via exfoliation using a mineral acid, and then subsequent reduction. The imperfect reduction usually yields C=O (or COOH) in the surface which makes the material an oxide (graphene oxide, GO), with a type of surface relevant for biomedical applications [14] (Fig. 3a, b). However, GO has been shown to have various toxicities in many in-vivo testing which includes platelet aggregation in mice. To address this, a promising approach developed by Singh et al. [15] involves the use of an amine-functionalized graphene to substitute the highly carboxylated GO. This work demonstrates that via functional group modification, the interaction of the material with living systems can be minimized.
![Fig. 3 TEM images of literature reported graphene [23], graphene oxide [24], and iron nanoparticles [25] respectively. Reprinted with permission from Refs. [23] (Copyright © 2007 Nature Publishing), [24] (Copyright © 2008 Elsevier Publishing), and [25] (Copyright © 2006 American Chemical Society).](/document/doi/10.1515/pac-2014-0302/asset/graphic/pac-2014-0302_fig3.jpg)
TEM images of literature reported graphene [23], graphene oxide [24], and iron nanoparticles [25] respectively. Reprinted with permission from Refs. [23] (Copyright © 2007 Nature Publishing), [24] (Copyright © 2008 Elsevier Publishing), and [25] (Copyright © 2006 American Chemical Society).
Carbon Nanotubes (CNTs)
Carbon nanotubes comprise another carbonaceous-type material with nanotubular shape which can also be excellent delivery systems. However, the hydrophobicity and insolubility of CNTs has been reported to cause chronic toxicities [16]. Studies in mice indicate that exposure to these materials may cause granulomas, inflammation, and necrosis within the bronchial region. After an exposure of at least 7 days, mice subjects developed acute inflammation, remarkably worsened in subjects exposed for 90 days [17]. Some experimental evidences also suggest that CNTs are capable of inducing an inflammatory response in epithelial cells by triggering interleukin-8 release from human epidermal keratinocytes [18]. Covalent surface modifications of CNTs are known to change the size and shape of CNTs and can provide more hydrophilic functional surface groups including C=O, COOH, etc. In general, oxidation of the surface of CNTs can make them less toxic because they can easily be further manipulated for biocompatibility.
Metal nanoparticles
Nanomaterials commonly engineered in research studies comprise metal (oxide) (Fig. 3c) particles that are capped/supported and eventually modified for specific applications. For drug delivery systems, nanoparticles are usually coated with biocompatible polymers not only to make the materials safer and resistant to degradation, but also to control drug release. Iron oxide nanoparticles, for example, can be coated with Polyethylene glycol or natural polymers (e.g., starch) to produce a magnetic and biocompatible nanoparticle that can be used to enhance magnetic targeting of a cancer tumor [19]. Similar coating procedures have been reported for gold and silver nanomaterials in order to improve their biocompatibility [20, 21].
Nanosafety testing and implementation
Safety protocols in handling nanomaterials should be institutionalized in every laboratory. As such, there should be full knowledge on the researchers’ end as to the hazards associated with handled nanosystems. With nanotechnology research significantly contributing and impacting the academic community in recent years, it is important to develop efficient and fast screening cytotoxicity methods to also establish appropriately safety protocols. It is also necessary to build a database containing the synthesized nanomaterials and their respective hazards to different types of cells as reported elsewhere in scientific literature.
Mechanism-based predictive toxicology approach
Predictive testing essentially describes a useful tool that factors in chemical composition, structure, crystal structure, shape, state of agglomeration as well as other surface properties of a nanomaterial to determine its response with high throughput screening, hazard ranking, and bioactivity [22]. Using a library of engineered nanomaterials, scientists can also predict potential molecular interactions between nanomaterials and cell surfaces. In order to start up a data set library, a comprehensive database of surface properties of materials including TiO2, CeO2, and ZnO has to be compiled and then tested for biological assay (oxygen-radical generation and pro-inflammatory responses in cells) [23]. A second important requirement relates to the development of a good high-throughput screening method, which in this case was performed in a 384-well plate. Healthy cell lines were exposed to specific dosages of the nanoparticles and then subsequently analysed for mitochondrial membrane potential, intracellular calcium influx as well as increased membrane permeability in dying cells [24]. Last, but not the least, studies and knowledge on the mechanism injury pathway taken by the cells in the presence of the nanoparticles are required essential information to complete the predictive model, with a data processing framework that can perform calculations based on the physico-chemical properties and HTS results. Using advanced mathematical computational methods, structure-activity relationships can be established and subsequently validated using a more systematic animal model study. Also, this predictive approach can be used to obtain pulmonary and environmental hazard assessments.
Biological assays
The use of different cell lines to determine nanomaterials cytotoxicity remains one of the most convenient and powerful methods of analysis to determine safety issues of nanoentities. Although biological assays are currently slowly moving towards the direction of high-throughput screening using large micro-well plates and more advanced imaging instruments, data gathered using traditional techniques are still of practical importance to toxicologists. Nanoparticles testing can often mask their actual toxicities because of many factors related to NP-assay component interactions [25], but data obtained in traditional assays serves as starting point for further in vivo animal testing (usually using mice).
In a comprehensive cytotoxicity screening conducted by Kroll et al. [26], 23 engineered nanomaterials (titania, aluminum, zirconium and their composites) were tested against ten different human cell lines, with results showing that most of the particles cause oxidative stress to the cells (Fig. 4). All but one of the nanomaterials did not reduce cellular metabolic activity. A similar study specifically utilized cancel cell lines such as osteocytic and HeLa to determine the toxicity of AuNP, AgNP and single-walled carbon nanotubes (SWCNT). SWCNT was found to be most toxic among the three nanomaterials. The observed toxicity of SWCNT to cancer cells certainly poses restrictions in its possible use as a safe carrier of chemotherapeutic agents [27].
![Fig. 4 HTS screening and data processing factoring in the surface properties of particles in order to predict the biological effects of nanoparticles. (Reprinted with permission from Ref. [26], Copyright © 2012 American Chemical Society.)](/document/doi/10.1515/pac-2014-0302/asset/graphic/pac-2014-0302_fig4.jpg)
HTS screening and data processing factoring in the surface properties of particles in order to predict the biological effects of nanoparticles. (Reprinted with permission from Ref. [26], Copyright © 2012 American Chemical Society.)
Laboratory practices for safer nanomaterials research
In terms of useful and safe practises to handle nanomaterials in research, laboratories can use three different control approaches in order to ensure a safety working environment: 1) engineering control (Fig. 5, highest panel), 2) administrative control, and 3) personal protective equipment (Fig. 5, two lower panels).

The first panel shows the engineering controls used in most laboratories. The two lower panels, on the other hand, show the personal protective equipment that should be used to ensure complete safety. Reproduced with permission from http://www.uvm.edu/safety/lab/ppe-gloves-lab-coats-respirator
Engineering control including the installation of ventilation, the preferential use of less toxic materials and the use of designated storage cabinets remained to be the most important aspect of laboratory safety. Administrative control, on the other hand, refers to the use of proper warning notices and appropriate chemical hazard labels. Although this could be effective, they could have the tendency to be overseen by the researchers involved. Lastly, personal protective equipment includes (the use of) appropriate gloves, lab coat, and face protection. Although third in the hierarchy of laboratory safety controls, personal protective equipment is considered every researcher’s first line of defences against danger [1, 28].
Conti et al. [29] recently surveyed the environmental and health safety practices of many laboratories worldwide towards engineered nanomaterials. Including key laboratories from Asia, North America, Australia, and Europe, the study showed that most laboratories strictly employ engineering controls to ensure safety, while most laboratories reported standard non-high efficiency particulate filters (non-HEPA). Some responded that they use more extensive air filter apparatus as well as wet scrubbers for water-soluble organic pollutants. For personal protective equipment (PPE), most institutions recommend nano-specific PPE depending on the type of research and development.
In a later survey conducted by Balas et al. [30] some appalling results were found as to how researchers handle nanomaterials in the laboratory by direct contact with researchers working on the field. By contacting almost 3000 researchers (of which 10 % responded) gathered from the Web of Knowledge database of publication, these authors were able to get a semi-randomized sample of the practices of many research laboratories worldwide. Roughly 90 % of the respondents were not aware of local and national regulations for nanosafety. More disturbingly, most respondents do not protect themselves even with the knowledge that handled NP could be airborne.
Although engineering controls remain to be the most important safety precaution in every laboratory, researchers should always take into account potential materials toxicity and conduct scientific procedures in the safest possible ways. Ideally, research laboratories should adopt a detailed laboratory safety protocol for nanosafety, with detailed knowledge between both researchers and supervisors on the toxicity and hazards of investigated nanomaterials. Secondly, handling procedures should be properly documented and reported by the researchers and kept in a file so that everyone in the lab can possibly access all safety protocols.
Many safety aspects of nanotechnology are already in place in many laboratories. Importantly, decision-making tools in handling nanomaterials have been proposed by experienced scientists in the field. The importance of risk assessments cannot be overlooked in every laboratory experiment. This does not only give the researchers an idea of the overall experimental flow, but also allows for the preconception of safety back-up plans in case a hazard occurs. A good risk assessment provides two important parts that are essential to ensure full safety: 1) hazard assessment and 2) exposure assessment (Fig. 6). A detailed risk assessment, risk characterization and risk management can be obtained when these two elements are put together [31, 32].
![Fig. 6 a) A good risk assessment prior to any experiment involves the evaluation of the chemical hazards and an estimate of the level of exposure. b) The creation of a risk assessment is the first step in producing a detailed risk management procedure involving prevention, mitigation, and communication. (Reprinted with permission from Ref. [26], Copyright © 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.)](/document/doi/10.1515/pac-2014-0302/asset/graphic/pac-2014-0302_fig6.jpg)
a) A good risk assessment prior to any experiment involves the evaluation of the chemical hazards and an estimate of the level of exposure. b) The creation of a risk assessment is the first step in producing a detailed risk management procedure involving prevention, mitigation, and communication. (Reprinted with permission from Ref. [26], Copyright © 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.)
A separate assessment is proposed by Meili et al. [33] divides nanomaterials into low, intermediate and high priority depending on their qualities and where they fit in a developed map for such purposes (Fig. 7). It is also important to determine the set of protocols that fit within each assessment level: What safety precautions should at least be present if the risk is considered a low, intermediate or high priority? These questions should be answered in detail and kept in file accessible to all researchers in the lab.
![Fig. 7 Risk assessment can be divided into a question-and-answer portion type of evaluation in order to determine whether the nanoparticle in question is considered a low priority, intermediate priority, and high priority. (Reprinted with permission from Ref. [31], Copyright © 2012 American Chemical Society.)](/document/doi/10.1515/pac-2014-0302/asset/graphic/pac-2014-0302_fig7.jpg)
Risk assessment can be divided into a question-and-answer portion type of evaluation in order to determine whether the nanoparticle in question is considered a low priority, intermediate priority, and high priority. (Reprinted with permission from Ref. [31], Copyright © 2012 American Chemical Society.)
Conclusion and prospects
Nanotechnology attracted a staggering degree of attention in recent years, leading to fascinating and unthinkable advances in miniaturisation and nanomaterials development in the past decade. Many of these in fact emerged without a clear understanding of potential implications for our future society in terms of environmental impact and hazards and toxicology, essentially due to unknown properties of nanomaterials. The field of nanotoxicology recently emerged due to the rising applications of nanotechnology in industries. This contribution has been aimed to set the basis for future studies in order to establish detailed nanosafety protocols that not only protect the researchers working on the materials but also the environment. As with any other experimental research, safety should be a priority, and this cannot be overemphasized. Experienced researchers have made the move on proposing for safety assessment methods that efficiently help every researcher protect himself, with several additional possibilities for benign by design methodologies for nanomaterials fabrication.
In the light of these premises, we sincerely hope that this contribution can pave the way towards more sustainable practises for nanomaterials design as well as stimulate discussion and further research for stricter nanosafety practices that combine a safer working environment in nanotechnology labs with better understood materials for environmentally safer and sound protocols.
Article note: A collection of invited papers based on presentations on the Environmental Chemistry theme at the 44th IUPAC Congress, Istanbul, Turkey, 11–16 August 2013.
References
[1] D. B. Warheit, C. M. Sayes, K. L. Reed, K. A. Swain. Pharmacol. Therapeut.120, 35 (2008).Search in Google Scholar
[2] M. Ferrari. Nat. Rev. Cancer.5, 161 (2005).10.1038/nrc1566Search in Google Scholar PubMed
[3] J. W. Park. Breast Cancer Res.4, 95 (2002).10.1186/bcr432Search in Google Scholar PubMed PubMed Central
[4] P. R. Srinivas, P. Barker, S. Srivastava. Lab. Invest.82, 657 (2002).Search in Google Scholar
[5] P. R. Bueno and C. Gabrielli. Nanostructured materials for electrochemical energy production and storage (E. R. Leite, ed.), pp. 81–149. Springer-Verlag, United States (2009).10.1007/978-0-387-49323-7_3Search in Google Scholar
[6] G. Oberdorster, A. Maynard, K. Donaldson, V. Castranova, J. Fitzpatrick, K. Ausman, J. Carter, B. Karn, W. Kreyling, D. Lai, S. Olin, N. Monteiro-Rivere, D. B. Warheit, H. Yang. Part. Fibre Toxicol.2, 8 (2005).Search in Google Scholar
[7] F. T. Andón, B. Fadeel. Acc. Chem. Res.46, 733 (2012).Search in Google Scholar
[8] Y. Pan, S. Neuss, A. Leifert, M. Fischler, F. Wen, U. Simon, G. Schmid, W. Brandau, W. Jahnen-Dechent. Small3, 1941 (2007).10.1002/smll.200700378Search in Google Scholar PubMed
[9] P. V. AshaRani, G. L. K. Mun, M. P. Hande, S. Valiyaveettil. ACS Nano3, 279 (2008).10.1021/nn800596wSearch in Google Scholar PubMed
[10] O. Akhavan, E. Ghaderi. ACS Nano4, 5731 (2010).10.1021/nn101390xSearch in Google Scholar PubMed
[11] S. T. Kim, K. Saha, C. Kim, V. M. Rotello. Acc. Chem. Res.46, 681 (2013).Search in Google Scholar
[12] J. Ai, E. Biazar, M. Jafarpour, M. Montazeri, A. Majdi, S. Aminifard, M. Zafari, H. R. Akbari, H. G. Rad. Int. J. Nanomed.6, 1117 (2011).Search in Google Scholar
[13] A. W. Kleingeld, L. Lorenzen, F. G. Botes. Chem. Eng. Sci.54, 4991 (1999).Search in Google Scholar
[14] Y. Zhang, T. R. Nayak, H. Hong, W. Cai. Nanoscale4, 3833 (2012).10.1039/c2nr31040fSearch in Google Scholar PubMed PubMed Central
[15] S. K. Singh, M. K. Singh, P. P. Kulkarni, V. K. Sonkar, J. J. A. Grácio, D. Dash. ACS Nano6, 2731 (2012).10.1021/nn300172tSearch in Google Scholar PubMed
[16] L. Yan, F. Zhao, S. Li, Z. Hu, Y. Zhao. Nanoscale3, 362 (2011).10.1039/C0NR00647ESearch in Google Scholar PubMed
[17] C. W. Lam, J. T. James, R. McCluskey, R. L. Hunter. Toxicol. Sci.77, 126 (2004).Search in Google Scholar
[18] N. A. Monteiro-Riviere, R. J. Nemanich, A. O. Inman, Y. Y. Wang, J. E. Riviere. Toxicol. Lett.155, 377 (2005).Search in Google Scholar
[19] A. J. Cole, A. E. David, J. Wang, C. J. Galbán, H. L. Hill, V. C. Yang. Biomaterials32, 2183 (2011).10.1016/j.biomaterials.2010.11.040Search in Google Scholar PubMed PubMed Central
[20] V. Dixit, J. Van den Bossche, D. M. Sherman, D. H. Thompson, R. P. Andres. Bioconjugate Chem.17, 603 (2006).Search in Google Scholar
[21] M. Tejamaya, I. Römer, R. C. Merrifield, J. R. Lead. Envi. Sci. Technol.46, 7011 (2012).Search in Google Scholar
[22] A. Nel, T. Xia, H. Meng, X. Wang, S. Lin, Z. Ji, H. Zhang. Acc. Chem. Res.46, 607 (2012).Search in Google Scholar
[23] T. Xia, M. Kovochich, M. Liong, L. Madler, B. Gilbert, H. Shi, J. I. Yeh, J. I. Zink, A. E. Nel. ACS Nano2, 2121 (2008).10.1021/nn800511kSearch in Google Scholar PubMed PubMed Central
[24] S. George, S. Pokhrel, T. Xia, B. Gilbert, Z. Ji, M. Schowalter, A. Rosenauer, R. Damoiseaux, K. A. Bradley, L. Madler, A. E. Nel. ACS Nano4, 15 (2010).10.1021/nn901503qSearch in Google Scholar PubMed PubMed Central
[25] J. Geys, B. Nemery, P. H. M. Hoet. Toxicol. In Vitro.24, 620 (2010).Search in Google Scholar
[26] A. Kroll, C. Dierker, C. Rommel, D. Hahn, W. Wohlleben, C. Schulze-Isfort, C. Gobbert, M. Voetz, F. Hardinghaus, J. Schnekenburger. Part. Fibre Toxicol.8, 9 (2011).Search in Google Scholar
[27] M. Mahmood, D. A. Casciano, T. Mocan, C. Iancu, Y. Xu, L. Mocan, D. T. Iancu, E. Dervishi, Z. Li, M. Abdalmuhsen, A. R. Biris, N. Ali, P. Howard, A. S. Biris. J. Appl. Toxicol.30, 74 (2010).Search in Google Scholar
[28] K. van der Jagt, E. Tielemans, I. Links, D. Brouwer, J. van Hemmen. J. Occup. Environ. Hyg.1, 355 (2004).Search in Google Scholar
[29] J. A. Conti, K. Killpack, G. Gerritzen, L. Huang, M. Mircheva, M. Delmas, B. H. Harthorn, R. P. Appelbaum, P. A. Holden. Environ. Sci. Technol.42, 3155 (2008).Search in Google Scholar
[30] F. Balas, M. Arruebo, J. Urrutia, J. Santamaria. Nat. Nanotechnol.5, 93 (2010).Search in Google Scholar
[31] C. Som, B. Nowack, H. F. Krug, P. Wick. Acc. Chem. Res.46, 863 (2012).Search in Google Scholar
[32] H. F. Krug, P. Wick. Angew. Chem. Int. Ed.50, 1260 (2011).Search in Google Scholar
[33] C. Meili, M. Widmer, F. Husmann, P. Gehr, F. Blank, M. Riediker, K. Schmid, W. Stark, L. Limbach. Synthetische Nanomaterialien. Risikobeurteilung und Risikomanagement. Grundlagenbericht zum Aktionsplan. Umwelt-Wissen Nr. 0721. Bundesamt fur Umwelt und Bundesamt fur Gesundheit, Bern. 284S (2007).Search in Google Scholar
©2014 IUPAC & De Gruyter Berlin/Boston
Articles in the same Issue
- Frontmatter
- Congress-44 Environmental Chemistry
- Preface
- 44th IUPAC Congress: Environmental Chemistry
- Conference papers
- Estimating the bioavailability of trace metals/metalloids and persistent organic substances in terrestrial environments: challenges and need for multidisciplinary approaches
- Chemical speciation in fresh, saline and hyper-saline waters
- Uranium toxicity and chelation therapy
- Analysis of trace elements in surface sediments, mussels, seagrass and seawater along the southeastern Adriatic coast – a chemometric approach
- Advances in understanding the transformation of engineered nanoparticles in the environment
- Novel Fe-Pd/SiO2 catalytic materials for degradation of chlorinated organic compounds in water
- Nanotechnology management for a safer work environment
- Bibliometric analysis of research on secondary organic aerosols: Update
- Surface-functionalized silica gel adsorbents for efficient remediation of cationic dyes
- Experimental study of cadmium bioaccumulation in three Mediterranean marine bivalve species: correlation with selected biomarkers
- Water scarcity, water reuse, and environmental safety
- ICHC-24
- Preface
- The 24th International Society of Heterocyclic Chemistry Congress (ICHC-24)
- Conference papers
- Organocatalytic asymmetric synthesis of chiral nitrogenous heterocycles and natural products
- Efficient asymmetric syntheses of alkaloids and medicinally relevant molecules based on heterocyclic chiral building blocks
- Naphthalimides for labeling and sensing applications
- Metal-catalyzed synthesis of heterocycles bearing a trifluoromethyl group
Articles in the same Issue
- Frontmatter
- Congress-44 Environmental Chemistry
- Preface
- 44th IUPAC Congress: Environmental Chemistry
- Conference papers
- Estimating the bioavailability of trace metals/metalloids and persistent organic substances in terrestrial environments: challenges and need for multidisciplinary approaches
- Chemical speciation in fresh, saline and hyper-saline waters
- Uranium toxicity and chelation therapy
- Analysis of trace elements in surface sediments, mussels, seagrass and seawater along the southeastern Adriatic coast – a chemometric approach
- Advances in understanding the transformation of engineered nanoparticles in the environment
- Novel Fe-Pd/SiO2 catalytic materials for degradation of chlorinated organic compounds in water
- Nanotechnology management for a safer work environment
- Bibliometric analysis of research on secondary organic aerosols: Update
- Surface-functionalized silica gel adsorbents for efficient remediation of cationic dyes
- Experimental study of cadmium bioaccumulation in three Mediterranean marine bivalve species: correlation with selected biomarkers
- Water scarcity, water reuse, and environmental safety
- ICHC-24
- Preface
- The 24th International Society of Heterocyclic Chemistry Congress (ICHC-24)
- Conference papers
- Organocatalytic asymmetric synthesis of chiral nitrogenous heterocycles and natural products
- Efficient asymmetric syntheses of alkaloids and medicinally relevant molecules based on heterocyclic chiral building blocks
- Naphthalimides for labeling and sensing applications
- Metal-catalyzed synthesis of heterocycles bearing a trifluoromethyl group